Mohammed S Inayat

RETRACTED ARTICLE: Didox (A Novel Ribonucleotide Reductase Inhibitor) Overcomes bcl-2 Mediated Radiation Resistance in Prostate Cancer Cell Line PC-3

Mohammed S Inayat, Chendil Damodaran, Mohammed Mohiuddin et al. · Cancer Biology & Therapy · 2002 · 100 citations · Full text

Farnesyltransferase inhibitor (L-744,832) restores TGF-β type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2

Rachael A. Alcock, Swatee Dey, Chendil Damodaran et al. · Oncogene · 2002 · 42 citations · Full text

Tumor Biology, Radiation Medicine, Pancreatic Cancer +9

A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: Effects of virus-induced immunomodulation on disease progression

Mahboob Qureshi, Beth A. Garvy, Claire Pomeroy et al. · Virus Research · 2005 · 27 citations

Viral Persistence, Disease Progression, Murine Model +9

Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease

Christopher N. Mayhew, Ryan Sumpter, Mohammed S Inayat et al. · Antiviral Research · 2004 · 15 citations

Lymphocyte Activation, Human Retrovirus, Immunology +9

In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease

L. Ryan Sumpter, Mohammed S Inayat, Erin E. Yost et al. · Antiviral Research · 2004 · 13 citations

Medicine, Human Retrovirus, Immunology +10